Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Recs

0
Player Avatar epocrates (< 20) Submitted: 2/2/2007 10:47:48 AM : Underperform Start Price: $3.48 THLD Score: -98.58

Pancreatic cancer is hard to show survival. Refractory pancreatic cancer is impossible to survival.

Featured Broker Partners


Advertisement